Top Institutions in Ophthalmology - Retinal Diseases
Leading academic medical centers and research institutions with strong ophthalmology and retinal disease programs typically conduct large-scale clinical trials, translational research, and drug development studies in nAMD. These institutions have extensive experience in retinal imaging, clinical trial design, and novel therapeutic mechanisms such as anti-VEGF and tyrosine kinase inhibitors.
-
#100
Bascom Palmer Eye Institute
Miami, FL
Bascom Palmer is consistently ranked as the top ophthalmology center in the US, with pioneering research in retinal diseases and leadership in clinical trials for novel AMD therapies including anti-VEGF agents and emerging treatments.
-
#92
Wills Eye Hospital
Philadelphia, PA
Wills Eye is renowned for its retinal disease research and clinical trial leadership, particularly in anti-VEGF therapies and novel drug delivery systems for AMD.
-
#89
Massachusetts Eye and Ear Infirmary
Boston, MA
Mass Eye and Ear has a strong history of innovation in retinal disease treatment, including early adoption and research of anti-VEGF therapies and novel agents targeting neovascular AMD.
-
#85
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is a leader in retinal disease research with a focus on innovative therapies and clinical trial design for AMD and other retinal vascular diseases.
-
#80
University of California San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF has a strong retinal disease program with expertise in clinical trials and translational research focused on AMD and innovative drug delivery systems.